SMi's 2nd Annual Conference Pharmaceutical Microbiology East Coast
April 10 - 11, 2019 - Boston MA USSMi Group
ssapal@smi-online.co.uk
Phone:02078276000
SPONSORS: Associates of Cape Cod, Charles River, bioMerieux, and DuPont CHAIRMAN: James Drinkwater, Chairman, Pharmaceutical and Healthcare Sciences Society The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding. In fact, the value of the rapid microbiology testing market is expected to reach USD 6.2 Billion by 2022, expanding at a CAGR of 7.3% from 2016 to 2022. Join industry experts to discuss and analyze the latest advances and challenges within the industry. Network with industry professionals, discuss the revision of Annex 1, explore data integrity considerations for conventional and rapid microbiology methods, analyze arising issues with environmental monitoring and gain insight into an industry perspective on automated endotoxin testing and process automation. Hashtag: #SMiPharmaMicroEC At the 2nd Annual Pharmaceutical Microbiology Conference, you will gain insight into • Design, validation and implementation of a documented and approved disinfectant programme • Effective use of environmental monitoring data trending • Rapid microbial methods • Challenges with endotoxin control • Advances in sterility assurance technology • Current regulations, challenges and trends in mycoplasma safety testing • A "deep dive" case study of atypical, low-level mold contamination PLUS.... Plus 2 half day interactive workshops on Friday, November 12, 2019. Workshop A: Mold Contamination Challenges - Led by: Microrite Inc Workshop B: Microbiological Control of GMP using Vapour Phase Hydrogen Peroxide bio-Decontamination – Led by: PHSS and Franz Ziel GmbH